IL-6 and metabolism - New evidence and new questions

Diabetologia

Volumn 51, Issue 7, 2008, Pages 1097-1099

  Krook, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Electro transfer; Insulin action; Insulin resistance; Interleukin 6

Indexed keywords

INTERLEUKIN 6;

GENE EXPRESSION; GLUCOSE TRANSPORT; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALS; ENERGY METABOLISM; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6;

EID: 44749090165     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-1019-7     Document Type: Note

References (18)

1. Kanemaki T, Kitade H, Kaibori M et al (1998) Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 27:1296-1303
2. Rotter V, Nagaev I, Smith U (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777-45784
3. Senn JJ, Klover PJ, Nowak IA, Mooney RA (2002) Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391-3399
4. Stouthard JM, Oude Elferink RP, Sauerwein HP (1996) Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun 220:241-245
5. Wallenius V, Wallenius K, Ahrén B et al (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79
6. Pedersen BK (2007) IL-6 signalling in exercise and disease. Biochem Soc Trans 035:1295-1297
7. Glund S, Krook A (2008) Role of interleukin-6 signalling in glucose and lipid metabolism. Acta Physiol (Oxf) 192:37-48
8. Pedersen BK, Febbraio MA, Mooney RA (2007) Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 102:814-819
9. Franckhauser S, Elias I, Rotter Sopasakis V et al (2008) Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight. Diabetologia DOI 10.1007/s00125-008-0998-8
10. Al-Khalili L, Bouzakri K, Glund S, Lönnqvist F, Koistinen HA, Krook A (2006) Signalling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 20:3364-3375
11. Carey AL, Steinberg GR, Macaulay SL et al (2006) IL-6 increases insulin stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMPK. Diabetes 55:2688-2697
12. Kelly M, Keller C, Avilucea PR et al (2004) AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Comm 320:449-454
13. Fischer CP (2006) Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 12:6-33
14. Faldt J, Wernstedt I, Fitzgerald SM, Wallenius K, Bergstrom G, Jansson J-O (2004) Reduced exercise endurance in interleukin-6-deficient mice. Endocrinology 145:2680-2686
15. Serrano AL, Baeza-Raja B, Perdiguero E, JardI M, Muñoz- Cánoves P (2008) Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 7:33-44
16. Ostrowski K, Rohde T, Zacho M, Asp S, Pedersen BK (1998) Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 508:949-953
17. Keller C, Steensberg A, Hansen AK, Fischer CP, Plomgaard P, Klarlund Pedersen B (2005) The effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol 99:2075-2079
18. Kolb H, Mandrup-Poulsen T (2005) An immune origin of type 2 diabetes. Diabetologia 48:1038-1050 (erratum in: Diabetologia 48:1677)